Author:
Khoshnazar S.M.,Dehghani A.,Bagheri F.,Pezeshki S.,Yousefzadeh G.
Funder
Kerman University of Medical Sciences
Reference30 articles.
1. Epidemiology of diabetes;Forouhi;Medicine (Abingdon, England: UK ed),2014
2. The double burden of diabetes and global infection in low and middle-income countries;Dunachie;Trans R Soc Trop,2019
3. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025;Lin;Sci Rep,2020
4. Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™);Zinman;Cardiovasc Diabetol,2014
5. Empagliflozin (Jardiance): a novel SGLT2 inhibitor for the treatment of type-2 diabetes;Ndefo;Pharm Ther,2015